These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8286212)

  • 41. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA; Workman P
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.
    Mahy P; De Bast M; Leveque PH; Gillart J; Labar D; Marchand J; Gregoire V
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1263-72. PubMed ID: 15197503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the noninvasive assessment of tumor hypoxia.
    Mannan RH; Mercer JR; Wiebe LI; Somayaji VV; Chapman JD
    Radiat Res; 1992 Dec; 132(3):368-74. PubMed ID: 1475360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of FoxP3(+) Cells in Canine Tumours and Lymph Nodes Correlates Positively with Glucose Transporter 1 Expression.
    Fortuna L; Relf J; Chang YM; Hibbert A; Martineau HM; Garden OA
    J Comp Pathol; 2016; 155(2-3):171-180. PubMed ID: 27435834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
    Bennewith KL; Durand RE
    Cancer Res; 2004 Sep; 64(17):6183-9. PubMed ID: 15342403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy.
    Seddon BM; Payne GS; Simmons L; Ruddle R; Grimshaw R; Tan S; Turner A; Raynaud F; Halbert G; Leach MO; Judson I; Workman P
    Clin Cancer Res; 2003 Nov; 9(14):5101-12. PubMed ID: 14613987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of hypoxia in canine cancer.
    Snyder SA; Dewhirst MW; Hauck ML
    Vet Comp Oncol; 2008 Dec; 6(4):213-23. PubMed ID: 19178681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
    Yaromina A; Quennet V; Zips D; Meyer S; Shakirin G; Walenta S; Mueller-Klieser W; Baumann M
    Int J Radiat Biol; 2009 Nov; 85(11):972-80. PubMed ID: 19895274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of tumor hypoxia by diffuse optical spectroscopy and immunohistochemistry in two tumor models.
    Maslennikova AV; Orlova AG; Golubiatnikov GY; Kamensky VA; Shakhova NM; Babaev AA; Snopova LB; Ivanova IP; Plekhanov VI; Prianikova TI; Turchin IV
    J Biophotonics; 2010 Dec; 3(12):743-51. PubMed ID: 20715133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelation of directly measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumours.
    Rohrer Bley C; Wergin M; Roos M; Grenacher B; Kaser-Hotz B
    Eur J Cancer; 2007 Mar; 43(5):963-7. PubMed ID: 17254768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model.
    Hendriksen EM; Span PN; Schuuring J; Peters JP; Sweep FC; van der Kogel AJ; Bussink J
    Microvasc Res; 2009 Mar; 77(2):96-103. PubMed ID: 19118564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
    Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
    Parliament MB; Chapman JD; Urtasun RC; McEwan AJ; Golberg L; Mercer JR; Mannan RH; Wiebe LI
    Br J Cancer; 1992 Jan; 65(1):90-5. PubMed ID: 1310253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration.
    Hodgkiss RJ; Stratford MR; Dennis MF; Hill SA
    Br J Cancer; 1995 Dec; 72(6):1462-8. PubMed ID: 8519660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of an enzyme-linked immunosorbent assay (ELISA) for the measurement of canine S100A12.
    Heilmann RM; Cranford SM; Ambrus A; Grützner N; Schellenberg S; Ruaux CG; Suchodolski JS; Steiner JM
    Vet Clin Pathol; 2016 Mar; 45(1):135-47. PubMed ID: 26765807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a monoclonal antibody-based indirect competitive enzyme-linked immunosorbent assay for nitroimidazoles in edible animal tissues and feeds.
    Han W; Pan Y; Wang Y; Chen D; Liu Z; Zhou Q; Feng L; Peng D; Yuan Z
    J Pharm Biomed Anal; 2016 Feb; 120():84-91. PubMed ID: 26717017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of serum Ki-67 as a biomarker in tumor-bearing dogs.
    Neumann S; Schuettler J; Frenz M; Kaup FJ; Gessler F
    Res Vet Sci; 2017 Feb; 110():16-21. PubMed ID: 28159231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia.
    Mannan RH; Mercer JR; Wiebe LI; Kumar P; Somayaji VV; Chapman JD
    J Nucl Biol Med (1991); 1992; 36(1):60-7. PubMed ID: 1450228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.